Jing X - Search Results

1

Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases.

Jia W, Zhai X, Jing X, Bao Q, Xu S, Zhu H, Wu G, Yu J. Jia W, et al. Among authors: jing x. J Neurooncol. 2023 Sep;164(2):321-330. doi: 10.1007/s11060-023-04426-z. Epub 2023 Aug 30. J Neurooncol. 2023. PMID: 37648933

2

Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer.

Jing X, Meng X, Sun X, Yu J. Jing X, et al. Onco Targets Ther. 2016 Feb 19;9:823-31. doi: 10.2147/OTT.S98765. eCollection 2016. Onco Targets Ther. 2016. PMID: 26929651 Free PMC article.

3

Pemetrexed Maintenance Therapy Following Bevacizumab-Containing First-Line Chemotherapy in Advanced Malignant Pleural Mesothelioma: A Case Report and Literatures Review.

Jing XQ, Zhou L, Sun XD, Yu JM, Meng X. Jing XQ, et al. Medicine (Baltimore). 2016 Apr;95(14):e3351. doi: 10.1097/MD.0000000000003351. Medicine (Baltimore). 2016. PMID: 27057918 Free PMC article. Review.

4

Ovarian metastasis from lung adenocarcinoma with ALK-positive rearrangement detected by next generation sequencing: A case report and literatures review.

Jing X, Li F, Meng X, Liu Z, Yu J, Liu B. Jing X, et al. Cancer Biol Ther. 2017 May 4;18(5):279-284. doi: 10.1080/15384047.2017.1310344. Epub 2017 Mar 31. Cancer Biol Ther. 2017. PMID: 28362192 Free PMC article.

5

A 4-month-old boy with gastrointestinal stromal tumor of mesocolon.

Jing X MD, Meng X MD, PhD, Gao Y MD, PhD, Yu J MD, PhD, Liu B MD, PhD. Jing X MD, et al. Among authors: jing x m d. Cancer Biol Ther. 2019;20(1):8-14. doi: 10.1080/15384047.2018.1504719. Epub 2018 Sep 25. Cancer Biol Ther. 2019. PMID: 30252568 Free PMC article.

6

An especially high rate of radiation pneumonitis observed in patients treated with thoracic radiotherapy and simultaneous osimertinib.

Jia W, Guo H, Jing W, Jing X, Li J, Wang M, Yu J, Zhu H. Jia W, et al. Among authors: jing w, jing x. Radiother Oncol. 2020 Nov;152:96-100. doi: 10.1016/j.radonc.2020.07.051. Epub 2020 Jul 31. Radiother Oncol. 2020. PMID: 32745669 Free article.

7

Clinical Outcomes for PD-1 Inhibitor Plus Chemotherapy as Second-Line or Later Therapy Compared to PD-1/PD-L1 Inhibitor Alone in Advanced Non-small-cell Lung Cancer.

Zhai X, Jing X, Li J, Tian Y, Xu S, Wang M, Zhu H. Zhai X, et al. Among authors: jing x. Front Oncol. 2020 Sep 30;10:556275. doi: 10.3389/fonc.2020.556275. eCollection 2020. Front Oncol. 2020. PMID: 33102221 Free PMC article.

8

Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy.

Tian Y, Ma J, Jing X, Zhai X, Li Y, Guo Z, Yu J, Zhu H. Tian Y, et al. Among authors: jing x. Cancer Lett. 2022 Aug 10;541:215719. doi: 10.1016/j.canlet.2022.215719. Epub 2022 May 18. Cancer Lett. 2022. PMID: 35597478 Review.

9

Severe Pulmonary Toxicity With Concurrent Anlotinib and Chemoradiotherapy in Stage III NSCLC: The ALTER-L042 Phase 1 Clinical Trial.

Zhu H, Jia W, Jing X, Huang W, Wang L, Yu J. Zhu H, et al. Among authors: jing x. JTO Clin Res Rep. 2022 May 13;3(6):100339. doi: 10.1016/j.jtocrr.2022.100339. eCollection 2022 Jun. JTO Clin Res Rep. 2022. PMID: 35663415 Free PMC article.

10

Programmed cell death 1 pathway inhibitors improve the overall survival of small cell lung cancer patients with brain metastases.

Chang J, Jing X, Hua Y, Geng K, Li R, Lu S, Zhu H, Zhang Y. Chang J, et al. Among authors: jing x. J Cancer Res Clin Oncol. 2023 May;149(5):1825-1833. doi: 10.1007/s00432-022-04121-y. Epub 2022 Jun 23. J Cancer Res Clin Oncol. 2023. PMID: 35737093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,278 results

Search Page

Filters